Stimulation of cannabinoid receptors by using Rubus coreanus extracts to control osteoporosis in aged male rats

References

• Lelovas PP, Xanthos TT, Thoma SE, et al. The laboratory rat as an animal model for osteoporosis research. Comp Med 2008;58:424–30
   PubMed Web of Science ®Google Scholar
• Gilbert SM, McKiernan JM. Epidemiology of male osteoporosis and prostate cancer. Curr Opin Urol 2005;15:23–7
   PubMedGoogle Scholar
• Bab I, Ofek O, Tam J, et al. Endocannabinoids and the regulation of bone metabolism. J Neuroendocrinol 2008;20:69–74
   PubMed Web of Science ®Google Scholar
• Smith MR. Osteoporosis in men with prostate cancer: now for the fracture data. J Clin Oncol 2008;26:4371–72
   Google Scholar
• Buchanan G, Greenberg NM, Scher HI, et al. Collocation of androgen receptor gene mutations in prostate cancer. Clin Cancer Res 2001;7:1273–81
   PubMed Web of Science ®Google Scholar
• Carson C III, Rittmaster R. The role of dihydrotestosterone in benign prostatic hyperplasia. Urology 2006;61:2–7
   Google Scholar
• Chen G, Sircar K, Aprikian A, et al. Expression of RANKL/RANK/OPG in primary and metastatic human prostate cancer as markers of disease stage and functional regulation. Cancer 2006;107:289–98
   PubMed Web of Science ®Google Scholar
• Urena P, Ferreira A, Kung VT, et al. Serum pyridinoline as a specific marker of collagen breakdown and bone metabolism in hemodialysis patients. J Bone Miner Res 1995;10:932–39
   PubMedGoogle Scholar
• Stanworth RD, Jones TH. Testosterone for the aging male; current evidence and recommended practice. Clin Interv Aging 2008;3:25–44
   PubMed Web of Science ®Google Scholar
• Saylor PJ, Smith MR. Bone health and prostate cancer. Prostate Cancer Prostatic Dis 2010;13:20–7
   PubMed Web of Science ®Google Scholar
• Pozzi S, Vallet S, Mukherjee S, et al. High-dose zoledronic acid impacts bone remodeling with effects on osteoblastic lineage and bone mechanical properties. Clin Cancer Res 2009;15:5829–39
   Google Scholar
• Putnam SE, Scutt AM, Bicknell K, et al. Natural products as alternative treatments for metabolic bone disorders and for maintenance of bone health. Phytother Res 2007;21:99–112
   PubMed Web of Science ®Google Scholar
• Alanis AD, Calzada F, Cedillo-Rivera R, Meckes M. Antiprotozoal activity of the constituents of Rubus coriifolius. Phytother Res 2003;17:681–82
   PubMed Web of Science ®Google Scholar
• Do SH, Lee JW, Jeong WI, et al. Bone-protecting effect of Rubus coreanus by dual regulation of osteoblasts and osteoclasts. Menopause 2008;15:676–83
   PubMed Web of Science ®Google Scholar
• Kim EJ, Lee YJ, Shin HK, Park JH. Induction of apoptosis by the aqueous extract of Rubus coreanum in HT-29 human colon cancer cells. Nutrition 2005;21:1141–8
   PubMed Web of Science ®Google Scholar
• Morimoto C, Satoh Y, Hara M, et al. Anti-obese action of raspberry ketone. Life Sci 2005;77:194–204
   PubMed Web of Science ®Google Scholar
• Park JH, Oh SM, Lim SS, et al. Induction of heme oxygenase-1 mediates the anti-inflammatory effects of the ethanol extract of Rubus coreanus in murine macrophages. Biochem Biophys Res Commun 2006;351:146–52
   PubMed Web of Science ®Google Scholar
• Choi CW, Lee HR, Lim HK, et al. Effect of Rubus coreanus extracts on diabetic osteoporosis by simultaneous regulation of osteoblasts and osteoclasts. Menopause 2012;19:1043–51
   Google Scholar
• McCormick DL, Rao KV, Dooley L, et al. Influence of N-methyl-N-nitrosourea, testosterone, and N-(4-hydroxyphenyl)-all-trans-retinamide on prostate cancer induction in Wistar-Unilever rats. Cancer Res 1998;58:3282–8
   PubMed Web of Science ®Google Scholar
• McCormick DL, Rao KV. Chemoprevention of hormone-dependent prostate cancer in the Wistar-Unilever rat. Eur Urol 1999;35:464–7
   PubMed Web of Science ®Google Scholar
• Scolnik MD, Servadio C, Abramovici A. Comparative study of experimentally induced benign and atypical hyperplasia in the ventral prostate of different rat strains. J Androl 1994;15:287–97
   PubMed Web of Science ®Google Scholar
• Hussain SA, Weston R, Stephenson RN, et al. Immediate dual energy X-ray absorptiometry reveals a high incidence of osteoporosis in patients with advanced prostate cancer before hormonal manipulation. BJU Int 2003;92:690–4
   PubMed Web of Science ®Google Scholar
• Smith MR, McGovern FJ, Fallon MA, et al. Low bone mineral density in hormone-naive men with prostate carcinoma. Cancer 2001;91:2238–45
   PubMed Web of Science ®Google Scholar
• Armstrong AP, Miller RE, Jones JC, et al. RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes. Prostate 2008;68:92–104
   PubMed Web of Science ®Google Scholar
• Yoshizawa T, Hinoi E, Jung DY, et al. The transcription factor ATF4 regulates glucose metabolism in mice through its expression in osteoblasts. J Clin Invest 2009;119:2807–17
   PubMed Web of Science ®Google Scholar
• Allain TJ. Prostate cancer, osteoporosis and fracture risk. Gerontology 2006;52:107–10
   Google Scholar
• Arunkumar A, Vijayababu MR, Venkataraman P, et al. Chemoprevention of rat prostate carcinogenesis by diallyl disulfide, an organosulfur compound of garlic. Biol Pharm Bull 2006;29:375–59
   PubMed Web of Science ®Google Scholar
• Shirai T, Takahashi S, Cui L, et al. Experimental prostate carcinogenesis – rodent models. Mutat Res 2000;462:219–26
   PubMed Web of Science ®Google Scholar
• Qian H, Zhao Y, Peng Y, et al. Activation of cannabinoid receptor CB2 regulates osteogenic and osteoclastogenic gene expression in human periodontal ligament cells. J Periodontal Res 2010;45:504–11
   PubMed Web of Science ®Google Scholar
• Bab I, Zimmer A. Cannabinoid receptors and the regulation of bone mass. Br J Pharmacol 2008;153:182–8
   PubMed Web of Science ®Google Scholar
• Idris AI, Sophocleous A, Landao-Bassonga E, et al. Cannabinoid receptor type 1 protects against age-related osteoporosis by regulating osteoblast and adipocyte differentiation in marrow stromal cells. Cell Metab 2009;10:139–47
   PubMed Web of Science ®Google Scholar
• Chung SC, Hammarsten P, Josefsson A, et al. A high cannabinoid CB(1) receptor immunoreactivity is associated with disease severity and outcome in prostate cancer. Eur J Cancer 2009;45:174–82
   PubMed Web of Science ®Google Scholar
• Czifra G, Varga A, Nyeste K, et al. Increased expressions of cannabinoid receptor-1 and transient receptor potential vanilloid-1 in human prostate carcinoma. J Cancer Res Clin Oncol 2009;135:507–14
   PubMed Web of Science ®Google Scholar